SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lane3 who wrote (96635)1/24/2005 10:52:57 PM
From: Ilaine   of 793866
 
Speaking from the perspective of a plaintiff's attorney, BiDil sounds like a potential litigation nightmare if it turns out that people who "look black" but are genetically indistinguishable from whites have more heart attacks while taking this medication.

Scenario: a man who "looks black" but has a high percentage of white/Asian/Native American/Latino ancestry takes BiDil and has a heart attack, and dies. His family wonders -- would he have been better off if he had taken another drug, say, one that is prescribed for whites?

So, they consult a cardiologist, who tells them that actually nobody really knows whether BiDil was better for ALL black people or just some. In fact, the dead man probably would have been better off with another treatment.

And there you have it. Minimum recovery in the millions.

Especially when you learn that genetic testing costs only a couple of hundred dollars per patient.

FYI, I am presently taking part in a clinical trial where my genetic material was assayed before the test and will be part of the test results. Not for any particular drug, it's actually a couple of tests involving rheumatoid arthritis and heart disease. They tested my heart and cardiac arteries and carotid arteries, and I have to keep them up to date on my medical treatment, every six months.

A simple buccal swab is all it takes.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News